The LOX concentrations that differed according to the type of tumor may also reflect that both re-modeled ECM (pre-cancerous niche - PCN) and normal-cell-to-cancer-cell transitions were encountered in different stages of completion, and thus the resulting expression levels were different. Here, LOX is linked to neoplasm.